Mercury From Silver Dental Fillings

August 5, 2011 at 9:16 pm | Posted in Uncategorized | Leave a comment
Tags: , , , ,
Mercury From Silver Dental Fillings

Research suggests that Mercury from Silver Dental Fillings may cause Depression, Excessive Anger, and Anxiety.

How is this possible you ask?  The study suggests that amalgam mercury may play a role in the cause of depression, excessive anger, and anxiety because mercury can produce such symptoms perhaps by affecting the neurotransmitters in the brain.

Scores on the Beck Depression Inventory were compared for 25 women who had silver dental fillings (amalgams) and for 23 women without amalgams. Women with amalgams had significantly higher scores and reported more symptoms of fatigue and insomnia. Anger scores from the State-Trait Anger Expression Inventory showed that the women with amalgams had statistically significantly higher mean scores on expressing anger without provocation and experiencing more intense angry feelings. The women without amalgams scored significantly higher on controlling anger, which suggested they invested more energy in monitoring and preventing the experience and expression of anger. Anxiety scores from the State-Trait Anxiety Inventory showed the women with amalgams scored significantly less pleasant, satisfied, happy, secure, and steady, and had a more difficult time making decisions. They had significantly higher Trait Anxiety scores. The women with amalgams also had significantly higher levels of mercury in the oral cavity before and after chewing gum. The study suggests that amalgam mercury may be an etiological (cause of) factor in depression, excessive anger, and anxiety because mercury can produce such symptoms perhaps by affecting the neurotransmitters in the brain.

Author: Siblerud RL; Motl J; Kienholz E

There is definitely more than enough evidence to show the toxicity effects mercury has on the brain and the central nervous system. I believe that Mercury actually physically deteriorate nerve tissues and it causes more than just a neurtransmitter embalance. Mercury destroys brain tissue and nerves and can reproduce the signs and symptoms of many degenerative neurological diseases such as MS and Alzheimer’s Disease. There is a great video ( ) where you can actually see how ions of Mercury (minute amounts) shrink the nerves growing in a petri dish. So is chronic neurological illness on the rise or is Mercury toxicity to blame? Please tell us your opinion on our blog

Chronic NSAID Use Doubles Cardiovascular Deaths in Elderly

August 5, 2011 at 6:35 pm | Posted in Uncategorized | Leave a comment
Tags: , , ,
Chronic NSAID Use Doubles Cardiovascular Deaths in Elderly

July 14, 2011 (Gainesville, Florida) — Older patients with hypertension and coronary artery disease who use nonsteroidal anti-inflammatory drugs (NSAIDs) chronically for pain are at significantly increased risk of cardiovascular events, a new post hoc analysis from the International Verapamil-Trandolapril Study (INVEST) demonstrates [1]. The research is published in the July 2011 issue of the American Journal of Medicine.

“We found a significant increase in adverse cardiovascular outcomes, primary driven by an increase in cardiovascular mortality,” lead author Dr Anthony A Bavry(University of Florida, Gainesville) told heartwire . “This is not the first study to show there is potential harm with these agents, but I think it further solidifies that concern.”

He says the observational study, conducted within the hypertension trial INVEST, is particularly relevant to everyday practice because the patients included were typical of those seen in internal-medicine, geriatric, and cardiology clinics–they were older, with hypertension and clinically stable CAD.

Bavry and colleagues were not able to differentiate between NSAIDs in the study–most people were taking ibuprofennaproxen, or celecoxib–and he says until further work is done, he considers the risks of NSAIDs “a class effect,” and their use should be avoided wherever possible.

I try to get them to switch to an alternative agent, such as acetaminophen.

However, “Patients should not terminate these medicines on their own,” he says. “They should have a discussion with their physician. When I see patients like these taking NSAIDs I will have an informed discussion with them and tell them there is evidence that these agents may be associated with harm. I try to get them to switch to an alternative agent, such as acetaminophen, or if that’s not possible I at least try to get them to reduce the dose of NSAID or the frequency of dosing. But ultimately, it’s up to them if this potential risk is worth taking depending upon the indication for their use.”

Chronic NSAID Use More Than Doubles CV Mortality

Within the large cohort of more than 22 000 patients in INVEST, Bavry and colleagues identified patients who reported taking NSAIDs at every follow-up visit and termed them chronic users (n=882). Most often, patients were taking these agents for conditions such as rheumatoid arthritis, osteoarthritis, and lower back pain, Bavry said.

They compared the chronic NSAID users with those who only intermittently (n=7286) or never (n=14 408) used NSAIDs over an average of 2.7 years and adjusted the findings for potential confounders.

The primary outcome–a composite of all-cause death, nonfatal MI, or nonfatal stroke–occurred at a rate of 4.4 events per 100 patient-years in the chronic-NSAID group vs 3.7 events per 100 patient-years in the nonchronic group (adjusted hazard ratio 1.47; p=0.0003).

As noted by Bavry, the end point was primarily driven by a more than doubling in the risk of death from CV causes in the chronic-NSAID group compared with never or infrequent users (adjusted HR 2.26; p<0.0001).

The association did not appear to be due to elevated blood pressure, the researchers say, because chronic NSAID users actually had slightly lower on-treatment BP over the follow-up period.

They note that a recent American Geriatrics Society panel on the treatment of chronic pain in the elderly recommends acetaminophen as a first-line agent and suggests that nonselective NSAIDs or COX-2 inhibitors be used only with extreme caution. “Our findings support this recommendation,” they state.

Bavry added: “We do need more studies to further characterize the risks of these agents, which are widely used and widely available, and perhaps the risks are underappreciated. We are working on the next level of studies to try to identify which are the most harmful agents.”

The majority of my patients taking NSAIDs on a regular basis for a prolonged amount of time take them to deal with muscle aches and joints. The warning I give to them – take them with food since they tend to upset your stomach especially if you have gastritis. I’m curious to know how long researchers knew about this information relating to NSAIDs? How many people have suffered or have even died because of this? The message I would like to leave you with – we have to remember that all drugs have an effect on the body, good and bad. When we neglect to treat the source of any pain or inflammation, and instead treat only the symptoms, it sometimes comes with a very high tag price. ~ Dr. Luis Flores

Blog at
Entries and comments feeds.